Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030 Given ... Read More
-
2023 Global Forecast for Plasma Fractionation Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2024 ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030
... & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030 Global Plasma Fractionation Market is valued approximately USD 30.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% ... Read More
-
Global Hemophilia Market - 2023-2030
... expected to exhibit a CAGR of 5.9% during the forecast period 2023-2030. A spectrum of conditions impacting the body's blood clotting function is comprehended as bleeding disorders. Heeding an injury, multiple disorders can induce extreme ... Read More
-
Fanconi Anemia Drug Market
... By Disease Stage (Early-stage Disease, Advanced-stage Disease), By Research Status (FDA-approved Drugs, Clinical Trials, Pre-clinical Studies, Pipeline Drugs), By Patient Setting (Inpatient Settings, Outpatient Settings), and By Geography (North America, Europe, Asia Pacific, Latin America, ... Read More
-
Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Von Willebrand Disease (vWD) Clinical trials scenario. This report provides top line data ... Read More
-
2023 Czech Republic Anemia Diagnostic Testing Market Assessment - 2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... from any other published source , including: - 2022 Supplier Sales and Shares by Segment and Test 2022-2027 Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies Opportunities ... Read More
-
Global Chemotherapy-Induced Anemia Market - 2023-2030
... chemotherapy-induced anemia market is expected to exhibit a cagr of 7.2% during the forecast period (2023-2030). Anemia is a condition in which the body's status of red blood cells goes below normal. When the body ... Read More
-
Global Anemia Gene Detection Kits Market Growth 2023-2029
... to grow at a CAGR of 4.8% from 2023 to 2029. United States market for Anemia Gene Detection Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Iron Deficiency Anemia (IDA) Therapy Market Forecasts to 2028 – Global Analysis By Therapy (Parenteral Iron Therapy, Oral Iron Therapy, Red Blood Cell Transfusion Therapy and Other Therapies), Therapy Area (Congestive Heart Failure (CHF), Renal, Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography
... Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography According to Stratistics MRC, the Global Iron Deficiency Anemia (IDA) Therapy Market is accounted for $1.87 billion in ... Read More
-
Global Thalassemia Market Size study & Forecast, by Therapeutic Class (Iron Chelating Drugs), by Pipeline (Gene Therapy) and Regional Analysis, 2022-2029
... to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. According to Centers for Disease Control and Prevention - Thalassemia can be defined as an inherited blood disorder caused ... Read More
-
Bleeding Disorders Market By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Treatment Type (Factor Replacement Therapy, Drug Therapy), By Distribution Channel (Hospital Pharmacies, Drug stores and retail pharmacies, Online pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The bleeding disorders market was valued at $13,789.66 million in 2022 and is estimated to reach $25,974.82 million by 2032, exhibiting a CAGR of 6.6% from 2023 to 2032. ... Read More
-
Middle East and Turkey Hemophilia Treatment Market, By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), By Disease Indication (Hemophilia A, Hemophilia B, and Hemophilia C), and By Country (Turkey, Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Hemophilia is rare disorder, in which the blood does not clot properly, and Bleeding after an ... Read More
-
Hemoglobinopathies- Market Insights, Competitive Landscape, and Market Forecast - 2027
... is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe The ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report provides ... Read More
-
Global Anemia in Pregnancy Market Growth 2023-2029
... CAGR of % from 2023 to 2029. United States market for Anemia in Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
... and End User (Hospitals, Clinics, and Others) The blood plasma derivatives market is expected to reach US$ 51,119.24 million by 2028 from US$ 29.886.12 million in 2022; it is estimated to record a CAGR of ... Read More
-
Global Haemophilia Drug Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Haemophilia Drug sales for 2023 through 2029. With Haemophilia Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Global Anemia Treatment Market Growth (Status and Outlook) 2023-2029
... carry oxygen.[5] When anemia comes on slowly, the symptoms are often vague and may include feeling tired, weakness, shortness of breath or a poor ability to exercise. LPI (LP Information)' newest research report, the “Anemia ... Read More
-
Global Sickle-cell Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). LPI (LP Information)' newest research report, the ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Renal Anemia Therapeutics sales for 2023 through 2029. With Renal Anemia Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 1.6 million diagnosed prevalent cases of ITP in 2023 across 16 pharmaceutical markets. There are four leading marketed innovator drugs for the treatment of ITP, majority of marketed products are thrombopoietin receptor agonist. R&D activity ... Read More
-
Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Thalassemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report includes ... Read More
-
Global Bleeding Disorders Treatment Market Size study & Forecast, by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), by Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Bleeding Disorders Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
Research Assistance
